DiFC
is
an
optical
technique
developed
by
our
group
for
identifying
and
monitoring
the
flow
of
circulating
tumor
cells
(CTCs)
other
rare
in
vasculature
vivo.
We
are
currently
able
to
detect
fluorescently
labelled
CTCs
anesthetized
mice
superficial
vessels
tail
hind
limb,
but
system
prone
motion
artifacts
stemming
from
involuntary
muscle
movements
cardiac
respiratory
cycles.
The
goal
this
work
quantify
sensitivity
using
a
custom
built
3-axis
simulating
arm
phantom,
develop
wearable
device
human
that
minimizes
artifacts.
results
investigational
phantom
study
suggest
sub-millimeter
displacements
between
probe
tips
tissue
higher
background,
lower
signal-to-noise
(SNR)
ratio
increased
false
alarm
rate.
designed
minimize
these
probe-tissue
compared
effectiveness
original
system.--Author's
abstract
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(6), P. 1712 - 1712
Published: June 12, 2023
Photodynamic
diagnostics
(PDD)
and
photodynamic
therapy
(PDT)
are
well-established
medical
technologies
used
for
the
diagnosis
treatment
of
malignant
neoplasms.
They
rely
on
use
photosensitizers,
light
oxygen
to
visualize
or
eliminate
cancer
cells.
This
review
demonstrates
recent
advancements
in
these
modalities
with
nanotechnology,
including
quantum
dots
as
innovative
photosensitizers
energy
donors,
liposomes
micelles.
Additionally,
this
literature
explores
combination
PDT
radiotherapy,
chemotherapy,
immunotherapy,
surgery
treating
various
The
article
also
focuses
latest
achievements
PDD
enhancements,
which
seem
be
very
promising
field
oncology.
ACS Nano,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 18, 2025
Tissue-resident
macrophages
(TRMs)
are
attractive
cells
to
therapeutically
deliver
oligonucleotide
and
other
gene-expression
modifying
modalities
treat
a
wide
array
of
diseases
ranging
from
inflammatory
autoimmune,
even
cancer.
Here,
we
focus
on
TRMs
located
inside
the
peritoneal
cavity
lining
abdomen
that
selectively
express
transcription
factor
GATA6
called
large
(GLPMs)
successfully
demonstrate
functional
GLPM-selective
delivery
Cy5-fluorophore-labeled
siRNA
encapsulated
in
C12–200
cationic-lipidoid-based
nanoparticles
(siRNA-Cy5
(C12–200)).
Despite
being
TRMs,
GLPMs
possess
specific
migratory
ability
peritoneally
liver
tissue
upon
injury
incited
by
acetaminophen
(APAP)
overdose
mice.
A
rapid,
injury-driven
tropism
carrying
siRNA-Cy5
(C12–200)
was
seen
via
systemic
circulation,
which
elegantly
demonstrated
using
noninvasive
live-cell
tracking
technique
diffuse
vivo
flow
cytometry
(DiFC).
Finally,
RNAi-mediated
silencing
well-known
pro-inflammatory
damage-associated
molecular
pattern
(DAMP)
High
Mobility
Group
Box-1
(HMGB1)
gene
led
mitigation
inflammation
prevention
GLPM
modulation
state,
further
translated
into
significant
protection
APAP-driven
reduction
circulating
cytokines
owing
muted
response
acute
injury.
Moreover,
HMGB1
GalNAc-conjugated
hepatocyte-targeting
did
not
reciprocate
findings,
solidifying
our
results.
Together,
data
suggested
act
as
carriers
rapidly
bringing
lipid
nanoparticle-encapsulated
RNAi
injured
have
emerged
viable
strategy
address
diseases,
especially
those
more
nature.
Advanced Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 27, 2025
Abstract
Immunocytotherapy
holds
significant
promise
as
a
novel
cancer
treatment,
but
its
effectiveness
is
often
hindered
by
delayed
responses,
requiring
evaluations
every
2–3
weeks
based
on
current
diagnostic
methods.
Early
assessment
of
immune
cell‐tumor
cell
interactions
could
provide
more
timely
insights
into
therapeutic
efficacy,
enabling
adjustments
to
treatment
plans.
In
this
study,
noninvasive
nanosensor
(C8R‐DSNP)
for
real‐time
monitoring
in
vivo
activities
the
second
near‐infrared
long‐wavelength
(NIR‐II‐L)
window
(1500–1900
nm),
which
offers
deep
tissue
transparency,
reported.
The
C8R‐DSNP
responds
rapidly
caspase‐8,
key
apoptotic
signaling
molecule
generated
during
between
natural
killer
(NK‐92)
cells
and
tumor
cells.
Using
ratiometric
NIR‐II‐L
fluorescence
imaging,
dynamic
observations
NK‐92
cells'
engagement
with
mouse
model
are
captured.
These
results
demonstrate
apoptosis
that
happens
early
4.5
h
after
infusion.
Additionally,
vitro
urine
imaging
confirmed
initiation
via
cleaved
fluorescent
small
molecules,
while
single‐cell
tracking
within
blood
vessels
tumors
further
elucidated
dynamics.
This
approach
valuable
optimizing
immunocytotherapy
strategies.
Journal of Biomedical Optics,
Journal Year:
2022,
Volume and Issue:
27(06)
Published: June 20, 2022
Significance:
“Diffuse
in
vivo
flow
cytometry”
(DiFC)
is
an
emerging
technology
for
fluorescence
detection
of
rare
circulating
cells
directly
large
deep-seated
blood
vessels
mice.
Because
DiFC
uses
highly
scattered
light,
principle,
it
could
be
translated
to
human
use.
However,
open
question
whether
fluorescent
signals
from
single
would
detectable
human-scale
anatomies.
Aim:
Suitable
a
wrist
or
forearm
are
at
depth
∼2
4
mm.
The
aim
this
work
was
study
the
impact
instrument
geometry
and
wavelength
on
detected
signal
maximum
moving
cell.
Approach:
We
used
Monte
Carlo
simulations
compute
Jacobian
(sensitivity)
matrices
range
source
detector
separations
(SDS)
tissue
optical
properties
over
visible
near
infrared
spectrum.
performed
experimental
measurements
with
three
available
versions
(488,
640,
780
nm),
microspheres,
mimicking
phantoms.
both
computational
data
estimate
each
combination
settings.
Results:
For
problem,
our
analysis
showed
that
vessels,
sensitivity
obtained
NIR
light
(780
nm)
3-mm
SDS.
Conclusions:
These
results
suggest
that—in
suitable
molecularly
targeted
probes—circulating
nanosensors
could,
circulation
humans.
Journal of Biomedical Optics,
Journal Year:
2023,
Volume and Issue:
28(07)
Published: July 22, 2023
Diffuse
in-vivo
Flow
Cytometry
(DiFC)
is
an
emerging
fluorescence
sensing
method
to
non-invasively
detect
labeled
circulating
cells
in-vivo.
However,
due
Signal-to-Noise
Ratio
(SNR)
constraints
largely
attributed
background
tissue
autofluorescence,
DiFC's
measurement
depth
limited.
multiplies
Aim:
The
Dual-Ratio
(DR)
/
dual-slope
a
new
optical
that
aims
suppress
noise
and
enhance
SNR
deep
regions.
We
aim
investigate
the
combination
of
DR
Near-InfraRed
(NIR)
DiFC
improve
cells'
maximum
detectable
SNR.
Biomedical Optics Express,
Journal Year:
2023,
Volume and Issue:
14(11), P. 5555 - 5555
Published: Sept. 26, 2023
In
this
work,
we
introduce
ratiometric
diffuse
in
vivo
flow
cytometry
(R-DiFC)
for
quantitative
measurement
of
circulating
fluorescent
red
blood
cell
(fRBC)
sensors
systemic
sodium
levels.
Unlike
our
previous
work
measuring
fRBC
sensors,
R-DiFC
allows
simultaneous
two
fluorophores
encapsulated
the
sensor,
ratio
which
enables
self-calibration
fluorescence
signal
with
different
depths
biological
tissue.
We
show
that
varies
significantly
less
than
either
alone.
This
holds
promise
personalized
monitoring
bipolar
patients
future.
Cytometry Part A,
Journal Year:
2023,
Volume and Issue:
103(11), P. 868 - 880
Published: July 17, 2023
Photoacoustic
flow
cytometry
is
one
of
the
most
effective
approaches
to
detect
"alien"
objects
in
bloodstream,
including
circulating
tumor
cells,
blood
clots,
parasites,
and
emboli.
However,
possibility
detecting
high-amplitude
signals
from
these
against
background
depends
on
parameters
laser
pulse.
So,
dependencies
photoacoustic
amplitude
number
pulse
energy
(5-150
μJ),
length
(1,
2,
5
ns),
repetition
rate
(2,
5,
10
kHz)
for
melanoma
cells
were
investigated.
First,
PA
responses
a
cell
suspension
vitro
measured
directly
assess
efficiency
converting
light
into
an
acoustic
signal.
After
it,
same
dependence
with
developed
murine
model
based
constant
injection
animal
was
tested.
Both
vivo
experiments
show
that
signal
generation
increases
above
15
μJ.
Shorter
pulses,
especially
1
ns,
provide
more
efficient
as
well
higher
rates.
A
also
provides
generation,
but
leads
overheating
skin.
The
results
limits
where
system
can
be
effectively
used
detection
undiluted
both
models.
Molecular Imaging and Biology,
Journal Year:
2024,
Volume and Issue:
26(4), P. 603 - 615
Published: April 9, 2024
Abstract
Purpose
We
recently
developed
an
optical
instrument
to
non-invasively
detect
fluorescently
labeled
circulating
tumor
cells
(CTCs)
in
mice
called
‘Diffuse
vivo
Flow
Cytometry’
(DiFC).
OTL38
is
a
folate
receptor
(FR)
targeted
near-infrared
(NIR)
contrast
agent
that
FDA
approved
for
use
fluorescence
guided
surgery
of
ovarian
and
lung
cancer.
In
this
work,
we
investigated
the
labeling
detection
FR
+
CTCs
with
DiFC.
Procedures
tested
cancer
cell
lines
(IGROV-1
L1210A)
as
well
FR-
MM.1S
suspensions
Human
Peripheral
Blood
Mononuclear
(PBMCs)
vitro
.
also
NIR-DIFC
L1210A
blood
circulation
nude
vivo.
Results
62%
IGROV-1
83%
were
above
non-specific
background
levels
PBMCs
compared
only
2%
cells.
could
be
directly
externally
detected
using
NIR-DiFC
low
false
positive
rates.
Conclusions
This
work
shows
feasibility
Although
further
refinement
DiFC
signal
processing
algorithms
testing
other
animal
models
needed,
may
eventually
pave
way
human